The Journal of clinical endocrinology and metabolism · 2025
Radiofrequency Ablation for Thyroid Nodules (RATED Study)-Analysis of a Learning Curve and Predictors of Success.
СтатьяНаблюдательное исследованиеМногоцентровое исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
van der Meeren Manon M D, Boers Tim, de Graaf Pim, Duvivier Katya M, Dreijerink Koen M A, Deden Laura N, Veendrick Peter, Cernohorsky Paul, Joosten Frank B M, Savelberg Angelique B M C, Braak Sicco J, Roerink Sean H P P, Versluis Michel, Manohar Srirang, Oyen Wim J G
Аннотация
CONTEXT: Radiofrequency ablation (RFA) is used as treatment for symptomatic thyroid nodules. Factors influencing the volume reduction ratio (VRR) at 12 months are not yet fully understood.
OBJECTIVE: The primary objective of this work was evaluating the VRR at 12 months after RFA. Secondary objectives were the assessment of a learning curve and factors influencing the VRR at 12 months.
METHODS: A retrospective observational cohort study was conducted at 3 Dutch referral hospitals of patients who underwent RFA for symptomatic thyroid nodules with available ultrasound (US) follow-up. Main outcome measures included US-based VRR at 12 months and chronologically numbered RFA procedures. All patients' baseline, treatment, and early follow-up factors were assessed for correlation with VRR at 12 months.
RESULTS: A total of 337 patients with 356 nodules were included in the learning curve analysis. VRR at 12 months increased for the first 20 treatments per center and stabilized thereafter, indicating a plateau phase after a learning curve. These initial cases were removed from further analysis. In the remaining 299 nodules, median VRR at 3, 6, and 12 months was 57.1%, 65.6%, and 70.8%. Baseline nodule volume negatively correlated with VRR at 12 months but VRR was high for every volume category. Energy delivered per volume did not correlate with VRR.
CONCLUSION: In RFA for thyroid nodules, a stable treatment efficacy is achieved after 20 treatments, with a median VRR of 70.8%. Baseline nodule volume, energy delivered, and prolonged follow-up 6 months after treatment may not be clinically relevant to predict treatment success.
OBJECTIVE: The primary objective of this work was evaluating the VRR at 12 months after RFA. Secondary objectives were the assessment of a learning curve and factors influencing the VRR at 12 months.
METHODS: A retrospective observational cohort study was conducted at 3 Dutch referral hospitals of patients who underwent RFA for symptomatic thyroid nodules with available ultrasound (US) follow-up. Main outcome measures included US-based VRR at 12 months and chronologically numbered RFA procedures. All patients' baseline, treatment, and early follow-up factors were assessed for correlation with VRR at 12 months.
RESULTS: A total of 337 patients with 356 nodules were included in the learning curve analysis. VRR at 12 months increased for the first 20 treatments per center and stabilized thereafter, indicating a plateau phase after a learning curve. These initial cases were removed from further analysis. In the remaining 299 nodules, median VRR at 3, 6, and 12 months was 57.1%, 65.6%, and 70.8%. Baseline nodule volume negatively correlated with VRR at 12 months but VRR was high for every volume category. Energy delivered per volume did not correlate with VRR.
CONCLUSION: In RFA for thyroid nodules, a stable treatment efficacy is achieved after 20 treatments, with a median VRR of 70.8%. Baseline nodule volume, energy delivered, and prolonged follow-up 6 months after treatment may not be clinically relevant to predict treatment success.